- Estimated deadline
- Jan 28, 2027
- Expected posting
- Sep 10, 2026
- Award size
- Not listed
- Total program funding
- $10M
- Expected awards
- 3
- Cost sharing
- Not required
- Funding type
- Cooperative agreement
- Category
- Health
Check this solicitation free
Grantee reads the full announcement and lists every required section, page limit, deadline, scoring criterion and compliance item. Takes about two minutes, no account needed.
About this opportunity
The Brain Research through Advancing Innovative Neurotechnologies® (BRAIN) Initiative along with other NIH Institutes and Centers (ICs) intends to publish a Notice of Funding Opportunity (NOFO) to encourage investigators to pursue first-in-human or early-stage clinical studies for recording and/or stimulating devices to treat central nervous system disorders and better understand the human brain. This NOFO will be a part of a milestone-driven program, involving collaborative activities with the program officer(s)/director(s) assigned to the funded projects and joint responsibility for the successful management of the program post-award. This NOFO will allow participation in the NIH BRAIN Initiative Public Private Partnership Program which aims to facilitate partnerships between clinical investigators and manufacturers of latest-generation stimulating and/or recording devices to conduct clinical research in the CNS. Through the PPP, the BRAIN Initiative is interested in reducing barriers to negotiating such partnerships and ensuring that new clinical studies leverage manufacturers' existing data. Data demonstrating safety and utility of these devices are very costly to obtain and pose a substantial barrier to research progress.
Applications may be Non-Significant Risk (NSR), such as non-invasive devices, or Significant Risk (SR) requiring an Investigational Device Exemption (IDE) from the FDA, such as chronic implants. The clinical study is expected to provide data to answer key questions about the function or final design of a device and is expected to provide information about the device function or final design that cannot be practically obtained through additional non-clinical assessments (e.g., bench top or animal studies) due to the novelty of the device or its intended use. Applications are not being solicited at this time. Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects.
Who can apply
- State governments
- Private universities
- Other Native American tribal organizations
- Independent school districts
- Public and state universities
- County governments
- Small businesses
- For-profit organizations
- Other (see eligibility)
- Nonprofits with 501(c)(3) status
- Nonprofits without 501(c)(3) status
- City or township governments
- Special district governments
- Public and Indian housing authorities
- Federally recognized tribal governments
Other Eligible ApplicantsIndian/Native American Tribal Governments (Other than Federally Recognized);Eligible Agencies of the Federal Government;U.S. Territory or Possession;Faith-based or Community-based Organizations;Regional Organizations;Non-domestic (non-U.S.) Entities (Foreign Institutions).
Agency contact
BRAIN Initiative Devices
Please contact via e-mail.
- Reads the full solicitation and lays out every required section
- Drafts each section with you, in your words
- Checks the draft against every requirement before you submit
How to write it
All guidesMore from NIH
All NIH funding- Closes in 1 dayRFA-HG-27-011
GREGoRi Data Coordination and Outreach Center (U01, Clinical Trials Not Allowed)
Deadline Oct 30, 2026(1d)Up to $1.3M
- Closes in 1 dayRFA-HG-27-013
GREGoRi Innovation Projects (U01 Clinical Trial Optional)
Deadline Oct 30, 2026(1d)Up to $500K
- Closes in 1 dayRFA-HG-27-012
GREGoRi Technology Integration Center (U01, Clinical Trials Optional)
Deadline Oct 30, 2026(1d)Up to $2.3M
- Closes in 1 dayPAR-27-045
HEAL Initiative: Whole Joint Health Program (R61/R33 Clinical Trial Required)
Deadline Oct 30, 2026(1d)
- Closes in 4 daysPAR-24-280
Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed)
Deadline Nov 2, 2026(4d)
- Closes in 4 daysPAR-24-279
Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61 Clinical Trial Required)
Deadline Nov 2, 2026(4d)
Get new funding every Monday
New federal opportunities and upcoming deadlines for NIH and more, in one short email. Free, unsubscribe anytime.
Details from Grants.gov, last updated Sep 10, 2026. Deadlines and requirements can change: always confirm them in the official notice.